Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/1991
12/26/1991WO1991019501A1 Intercellular adhesion mediators
12/26/1991WO1991019419A1 Pasteurella multocida toxoid vaccines
12/26/1991WO1991017773A3 New protein-polycation conjugates
12/26/1991WO1991017187A3 A 35kd tumor associated protein antigen: uses and methods of detection
12/26/1991CA2085370A1 The retrovirus siv cpz-ant and its uses
12/26/1991CA2045326A1 Non-a, non-b, hepatitis virus particles
12/24/1991US5075425 Process for the preparation of a pharmaceutical which contains igg, iga and igm and can be administered intravenously
12/24/1991US5075287 Enhance activity of vaccines, bactericides, antitumor agents
12/24/1991US5075224 Prepro-LHRH C-terminal peptide DNA
12/24/1991US5075213 Probe capable of stable hybridization; DNA fragment coding for viral matrix protein
12/24/1991US5075211 Complexing antibodies with oligopeptides, blood screening
12/24/1991US5075110 Adding ureas, amides, carbamates, or their thio analogs before or after freeze drying
12/24/1991US5075109 Administering in encapsulated form
12/24/1991US5075108 Acylation of mephalan by an anhydride
12/23/1991WO1992000100A1 Improved ascites production of monoclonal antibodies using an immunosuppressive anti-cd4-related antibody
12/23/1991WO1992000096A1 Vaccine composition for treating human chlamydial diseases
12/23/1991CA2085586A1 Ascites production of monoclonal antibodies using an immunosuppressive anti-cd4-related antibody
12/23/1991CA2065320A1 Vaccine composition for treatment of human ailments due to chlamydiae
12/23/1991CA2044908A1 In vivo targeting with bifuncitonal antibodies
12/22/1991CA2045071A1 Acellular anti-pertussis vaccines
12/22/1991CA2043992A1 Use of cytokine-containing aerosols and the cytokine-containing aerosols
12/21/1991WO1991019798A1 Vectors containing hiv packaging sequences, packaging defective hiv vectors, and uses thereof
12/21/1991WO1991019729A1 Nucleic acid probes and protein probes
12/21/1991CA2084659A1 Vectors containing hiv packaging sequences, packaging defective hiv vectors, and uses thereof
12/21/1991CA2059559A1 Nucleic acid probes and protein probes
12/20/1991WO1991019795A1 Nonpathogenic variant virus
12/20/1991WO1991019786A1 Type-c rotavirus cultures and uses therefor
12/20/1991CA2085897A1 Nonpathogenic variant virus
12/20/1991CA2076396A1 Type-c rotavirus cultures and uses therefor
12/20/1991CA2044535A1 Non-a, non-b hepatitis virus genome rna, cdna and virus antigen protein
12/19/1991WO1991019736A2 Cancer-associated scm-recognition factor, preparation and method of use
12/19/1991DE4018988A1 New Borrelia burgdorferi proteins
12/19/1991CA2084767A1 Cancer-associated scm-recognition factor, preparation and method of use
12/19/1991CA2044741A1 Hiv gp120 monoclonal antibodies
12/18/1991EP0461177A1 Human intra-acrosomal sperm antigen for use in a contraceptive vaccine
12/18/1991CN1057072A Monoclonal anti-igm antibodies, their production and use, and hybridomas for producing same
12/17/1991USRE33772 Deletion mutant of a herpesvirus and vaccine containing said virus
12/17/1991US5073628 Hyposensitization agent
12/17/1991CA1293191C Vaccine composition for immunization against urinary tract infection caused by e. coli
12/17/1991CA1293190C Antiviral immunotherapeutic agent and preparation thereof
12/17/1991CA1293188C Composition of matter and method of immunizing against viral causative agents of aids and arc
12/16/1991WO1991019502A1 Intercellular adhesion mediators
12/16/1991CA2084888A1 Intercellular adhesion mediators
12/12/1991WO1991019739A1 Multivalent antigen-binding proteins
12/12/1991WO1991019725A2 Heterocyclic anthracyclione and anthracycline analogs
12/12/1991WO1991019498A1 Treatment of organ transplantation rejection
12/12/1991WO1991019009A1 The ciliary neurotrophic factor receptor
12/12/1991WO1991018928A1 Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type i (hiv-1) gp120 and methods of use
12/12/1991WO1991018926A1 PROTEIN D - AN IgD-BINDING PROTEIN OF HAEMOPHILUS INFLUENZAE
12/12/1991WO1991018922A1 16 kDa SURFACE PROTEIN OF $i(P. FALCIPARUM)
12/12/1991WO1991018627A1 Swine pneumonia vaccine and method for the preparation thereof
12/12/1991WO1991018619A1 Apo ai polypeptides, antibodies, and immunoassays
12/12/1991WO1991015512A3 Hiv envelope polypeptides
12/12/1991CA2085120A1 Heterocyclic anthracyclinone and anthracycline analogs
12/12/1991CA2085002A1 Treatment of organ transplantation rejection
12/12/1991CA2064829A1 Multivalent antigen-binding proteins
12/11/1991EP0460607A2 Novel monoclonal antibody to novel antigen associated with human tumors
12/11/1991EP0460480A2 Bacterin for the treatment of necrophorum diseases and a method for the production thereof
12/11/1991EP0460177A1 Method for intensive, in vitro culture of babesia divergens strains, method for preparing exoantigens and vaccines containing these antigens
12/11/1991EP0460072A1 Human elastase inhibitor
12/11/1991EP0460056A1 Non-a, non-b hepatitis hepatocyte cell culture
12/11/1991EP0460014A1 Chymopapain fragmentation of monoclonal antibodies
12/11/1991EP0235187B1 Polypeptides and antibodies characteristic of the papillomavirus, methods of diagnosis and vaccines in which they are used
12/11/1991CN1056816A Improved vaccine compositions
12/10/1991US5071963 Interferon-induced human (2'-5') oligo a synthetase
12/10/1991US5071954 Used for immunization of animals and purification of specific antibodies; purity
12/10/1991US5071761 Dna sequence coding for human lymphoblastoid interferons
12/10/1991US5071758 Veterinary medicine
12/10/1991US5071757 Incubating human tissue susceptible to the virus, placing it beneath renal capsule in immunocompromised animal and determining the effect of tissue
12/10/1991US5071744 Fusing b-lymphocytes from immunized fouse with a transforming agent; cloning; elisa; enzyme inhibition
12/10/1991US5071651 Rotavirus nucleocapsid protein VP6 as a carrier in vaccine compositions
12/09/1991WO1991018626A1 Method for detecting immune dysfunction in asymptomatic aids patients and for predicting organ transplant rejection
12/07/1991WO1991018920A1 Sm-d antigen peptides and their use, in particular, for the diagnosis of systemic lupus erythematosus
12/07/1991WO1991018617A1 Immunostimulant drug based on polar glycopeptidolipids of mycobacterium chelonae
12/07/1991CA2064576A1 Sm-d antigen peptides and their use notably in the diagnostic of systemic lupus erythematosus
12/06/1991WO1991018979A1 Method of isolating restriction fragment deletions in vibrio cholerae, and products thereof
12/06/1991CA2043951A1 Monoclonal antibody to novel antigen associated with human tumors
12/04/1991EP0459842A1 Process for the production of retroviral immunogenes and vaccines against retroviral infections, especially HIV, and immunogens and vaccines thereof
12/04/1991EP0459779A1 Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type I (HIV-1) GP120 and methods of use
12/04/1991EP0459577A2 Microbially expressed portions of a monoclonal antibody block rhinovirus attachment to cell receptors
12/04/1991EP0459450A2 Monoclonal antibody recognizing membrane phospholipase A2 and immunoassay of membrane phospholipase A2
12/04/1991EP0459387A2 Phencyclidine and phencyclidine metabolites assay, tracers, immunogens, antibodies and reagent kit
12/04/1991EP0458911A1 ENDOTHELIAL CELL-LEUKOCYTE ADHESION MOLECULES (ELAMs) AND MOLECULES INVOLVED IN LEUKOCYTE ADHESION (MILAs)
12/04/1991EP0182888B1 Method and reactant for the differential determination of isoenzymes of the alkaline phosphatase and monoclonal antibody therefore
12/04/1991CN1056713A Anti-oncostatin m monoclonal antibodies
12/03/1991US5069902 Attenuated strain of virus of contagious turkey rhinotrach-rhinotracheitis
12/03/1991US5069901 Deactivated antigens
12/03/1991US5069896 Malodor inhibiting skin deodorant composition comprising a monoclonal antibody and method of deodorizing
12/03/1991CA1292839C Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen
12/03/1991CA1292708C Monoclonal antibody against plasminogen-activating factor
12/03/1991CA1292691C Method for the effective treatment of disease conditions in humans associated with htl virus infection
12/03/1991CA1292690C Vaccine comprising an immunogenic protein and, as an adjuvant, a substantially non-immunogenic sequentially homologous peptide
12/03/1991CA1292689C Live vaccine for contagious disease of chickens
12/02/1991CA2043620A1 Microbially expressed portions of a monoclonal antibody block rhinovirus attachment to cell receptors
11/1991
11/30/1991CA2043372A1 Phencyclidine and phencyclidine metabolites assay, tracers, immunogens, antibodies and reagent kit
11/28/1991WO1991018454A1 Compositions capable of blocking cytotoxicity of viral regulatory proteins and neurotoxic symptoms associated with retroviral infection
11/28/1991WO1991018092A1 Acid-tolerant salmonella typhi, double aro mutants thereof and use as an oral vaccine for typhoid fever
11/28/1991WO1991018089A1 Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome
11/28/1991WO1991018013A1 Synthetic senescent cell antigen
11/28/1991WO1991017773A2 New protein-polycation conjugates
1 ... 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 ... 1823